Jonathan Moss

New Jersey Department of Education — United States

Neuroscience · Life Sciences

42h-index6.1kcitations161works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuropeptides and Animal Physiology(19), Anesthesia and Pain Management(17), Cancer, Stress, Anesthesia, and Immune Response(16), Anesthesia and Sedative Agents(15), Drug-Induced Adverse Reactions(13)

Publications158 total

Patient and clinician perspectives on the diagnosis and management of polycythemia vera: Results from concurrent surveys
Blood·2025Open Access
Multiregional blood-brain barrier phenotyping identifies the prefrontal cortex as the most vulnerable region to ageing in mice
2025Open Access
Multiregional blood-brain barrier phenotyping identifies the prefrontal cortex as the most vulnerable region to ageing in mice
Brain Communications·2025· 1 citedOpen Access
Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
Clinical Pharmacology & Therapeutics·2024· 4 citedOpen Access
Pooled Exposure-Response (ER) and Quantitative Benefit/Risk (B/R) Analyses Support the Approved Copanlisib Intermittent Dosing Regimen
Blood·2023Open Access
Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab
CPT Pharmacometrics & Systems Pharmacology·2023· 6 citedOpen Access
Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors
Clinical and Translational Science·2023· 3 citedOpen Access
Population Pharmacokinetics and Exposure-Response Analyses from Phase I-III Studies Support Copanlisib Dose Selection in Relapsed Indolent Non-Hodgkin Lymphoma
Blood·2022
Abstract A25: Copanlisib population pharmacokinetics (popPK) and exposure-response (ER) in relapsed indolent non-Hodgkin lymphoma (iNHL): Analysis from the 1-year follow-up of the phase III, randomized CHRONOS-3 trial
Blood Cancer Discovery·2022· 1 cited
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine·2021· 531 citedOpen Access
Parvalbumin interneurons mediate neuronal circuitry–neurogenesis coupling in the adult hippocampus
UNC Libraries·2020· 8 citedOpen Access
Opening the floodgates to the brain
Science·2020· 7 cited
Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial
Targeted Oncology·2019· 91 citedOpen Access
Contextualising women’s workplace activism in post-war England
Manchester University Press eBooks·2019
The Ford Sewing machinists’ strike, Dagenham, 1984–85
Manchester University Press eBooks·2019
Introduction
Manchester University Press eBooks·2019
Conclusion
Manchester University Press eBooks·2019
Sexton’s shoe factory occupation and Fakenham Enterprises, Norfolk, 1972–77
Manchester University Press eBooks·2019
The Trico-Folberth equal pay strike, Brentford, 1976
Manchester University Press eBooks·2019
The Ford Sewing machinists’ strike, 1968, Dagenham
Manchester University Press eBooks·2019
page 1 of 8Next →

Frequent Co-authors

Chun‐Su Yuan(12), Patrick A. Singleton(9), Carl E. Rosow(7), Joseph Foss(7), Michael O’Connor(7), Daniel M. Philbin(6), Michael F. Roizen(6), Frances E. Lennon(5), R. Hoernecke(5), Joe G. N. Garcia(4), Ravi Salgia(4), Α. Doenicke(4), John J. Savarese(3), Tamara Mirzapoiazova(3), Elke Czeslick(3), Biji Mathew(2), Jessica Siegler(2), Nurbek Mambetsariev(2), Saad Sammani(2), Gang Wei(2)